,8 ER stress in situ, coordinated by the activation of inositol-requiring enzyme-1α (IRE1α) and PRKR-like ER kinase (PERK), facilitates tumor growth and drug resistance and governs multiple pro-tumoral attributes by reprogramming the function of immune infiltrates.7 The gene discussed is ERN1; the disease is neoplasm.